These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Pharmacologic profile of protirelin tartrate]. Angelucci L; Lorentz G; Maccari S; Patacchioli FR; Scaccianoce S; Taglialatela G Ann Ital Med Int; 1990; 5(3 Pt 2):232-44. PubMed ID: 2127684 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of amyotrophic lateral sclerosis with TRH]. Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705 [TBL] [Abstract][Full Text] [Related]
10. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models. Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210 [TBL] [Abstract][Full Text] [Related]
11. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
12. Multiple injections of thyrotropin releasing hormone fail to reverse learning and memory deficits in rats with lesions of the nucleus basalis of meynert. Santucci AC; Perez S Behav Brain Res; 2002 Nov; 136(2):433-8. PubMed ID: 12429405 [TBL] [Abstract][Full Text] [Related]
13. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: possible clinical implications. Hawkins EF; Engel WK Life Sci; 1985 Feb; 36(6):601-11. PubMed ID: 2982071 [TBL] [Abstract][Full Text] [Related]
15. Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417. Hawley RJ; Kratz R; Goodman RR; McCutchen CB; Sirdofsky M; Hanson PA Neurology; 1987 Apr; 37(4):715-7. PubMed ID: 3104820 [TBL] [Abstract][Full Text] [Related]
16. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. Kaplan MM; Taft JA; Reichlin S; Munsat TL J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628 [TBL] [Abstract][Full Text] [Related]
17. Thyrotrophin-releasing hormone. New applications in the clinic. Griffiths EC Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448 [No Abstract] [Full Text] [Related]
18. High-dose TRH treatment of neuromuscular diseases: summary of mechanisms and critique of clinical studies. Summary of section IX. Engel WK Ann N Y Acad Sci; 1989; 553():462-72. PubMed ID: 2497686 [No Abstract] [Full Text] [Related]